Urethritis secondary prevention
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]
Overview
In order to prevent transmission to one’s partner and decrease the risk of antibiotic resistance, all patients must be instructed on safe sex practices and screening requirements after treatment.
Secondary Prevention
- Patients should be instructed on safe sex practices.
- All sex partners with whom a patient has engaged within the last 60 days must be evaluated for possible urethritis.
- Patients should be screened for other sexually transmitted diseases (e.g., HIV, syphilis).
- All patients must be retested 3 months after treatment to evaluate the risk of antibiotic resistance.
- Prophylactic ocular antimicrobial medication is strongly recommended for all newborns exposed to Neisseria gonorrhoeae during birth.
- Gonorrhea and Chlamydia are reportable diseases to the CDC, and practitioners should contact their local state health department upon diagnosing these diseases.[1][2][3]
References
- ↑ Bennett, John (2015). Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. Philadelphia, PA: Elsevier/Saunders. ISBN 9781455748013.
- ↑ Workowski KA, Bolan GA (2015). “Sexually transmitted diseases treatment guidelines, 2015”. MMWR Recomm Rep. 64 (RR-03): 1–137. PMID 26042815.
- ↑ Brill JR (2010). “Diagnosis and treatment of urethritis in men”. Am Fam Physician. 81 (7): 873–8. PMID 20353145.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH